Dr. Brown, there are many complementary or natural treatments available for our patients. Which treatments have you have found particularly helpful in your practice?
Combining medication and behavioral therapy leads to better outcomes for children with pervasive developmental disorders (PDDs), according to a recent study.
We know that headaches are common in the general population, but they are particularly common among patients with psychiatric problems. According to one review, (Pompili M et al., J Headache Pain 2009; 10(4):283-290) patients with depression have a 46% lifetime prevalence of migraine, while bipolar patients have a 51% prevalence. Patients with migraines have triple the risk of developing depression than patients without migraines.
Omega-3 fatty acids have been studied in a number of psychiatric disorders, including autism, bipolar disorder, depression, and schizophrenia. A new study shows a possible benefit for patients with a history of self-harm.
Vitamin E, recommended variously for preventing cardiovascular disease, Alzheimer’s disease, and tardive dyskinesia, has taken quite a drubbing in recent years. Recent results from Harvard’s Women's Health Study have put another nail in its coffin.
There are several natural treatments out there that may be helpful in psychiatry. Recently, the British Journal of Psychiatry published a review of “complementary medicines in psychiatry,” (Br J Psychiatry 2006;188:109-121). Based on this paper and our own review of recent better quality studies, TCPR offers the following list of potentially useful natural treatments.
A number of natural treatments have been subjected to the same kinds of rigorous double blind studies required of conventional medications and they have fared poorly. Four of the most commercially popular of these treatments have received particularly harsh treatment from the scientific method.
David Mischoulon, MD, PhD
Assistant Professor of Psychiatry, Harvard Medical School
Director of Alternative Remedy Studies, Depression Clinical and Research Program, Massachusetts General Hospital
Dr. Mischoulon has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity. The author has disclosed that acupuncture has not been approved by the U.S. Food and Drug Administration for use in the treatment of depression or substance abuse. Please consult product labeling for the approved usage of this treatment.
Dr. Mischoulon, thank you for returning to the pages of The Carlat Psychiatry Report. I know that since our last interview, you have been involved in studying the use of acupuncture in psychiatry. Tell us about that.